Skip to main content
Caplight Logo









AcornMed Biotechnology Co., Ltd.

AcornMed Biotechnology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://acornmed.com/

Last Round

Series B

Dec 27, 2022

Total Funding Raised

$42.79M

Company Overview

AcornMed Biotechnology Co., Ltd. is a precision medicine company that develops non-invasive genomic testing solutions for cancer screening, diagnosis, and monitoring.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

precision medicinegenomic testingliquid biopsy testliquid biopsynext-generation sequencingNGScancer genomicsoncology diagnosticscancer screeningcompanion diagnosticsmolecular diagnosticsbiomarker discoveryclinical laboratory servicescancer monitoringgenomic database

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AcornMed Biotechnology Co., Ltd. Comparables

Compare AcornMed Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

AcornMed Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
求臻医学
85%
HaploX
84%
Geneseeq
84%

AcornMed Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 27, 2022
Series AApr 8, 2020
AngelJul 1, 2018

AcornMed Biotechnology Co., Ltd. Investors

Notable investors and investment history

AcornMed Biotechnology Co., Ltd. investors
InvestorRounds
Sino-Ocean CapitalSeries A
Pragmatic CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 27, 2022

    $29M round led by Pragmatic Capital.

  • Apr 8, 2020

    $14.14M round led by Sino-Ocean Capital.

AcornMed Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AcornMed Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AcornMed Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range7
Year Founded2018
Last FundingDec 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?